Tumor necrosis factor-α and lymphotoxin-α increase macrophage ABCA1 by gene expression and protein stabilization via different receptors

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 387-392

  Edgel, Kimberly A ^a   LeBoeuf, Renée C ^a   Oram, John F ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

ABCA1; Atherosclerosis; Lymphotoxin; Mice; Tumor necrosis factor receptor

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; LYMPHOTOXIN; MESSENGER RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHEMOKINE CXCL13; LYMPHOTOXIN-ALPHA; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950019515     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.10.019     Document Type: Article

References (44)

1. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
2. Boesten L.S., Zadelaar A.S., van Nieuwkoop A., et al. Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice. Cardiovasc Res 2005, 66:179-185.
3. Schreyer S.A., Peschon J.J., LeBoeuf R.C. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem 1996, 271:26174-26178.
4. Schreyer S.A., Vick C.M., LeBoeuf R.C. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J Biol Chem 2002, 277:12364-12368.
5. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003, 3:745-756.
6. Oram J.F. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 2003, 23:720-727.
7. Oram J.F., Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 2005, 85:1343-1372.
8. Assmann G., von Eckardstein A., Brewer H.B.J. Familial high density lipoprotein deficiency: tangier disease. The Metabolic and Molecular Bases of Inherited Disease 1995, McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
9. Clee S.M., Kastelein J.J., van Dam M., et al. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 2000, 106:1263-1270.
10. Serfaty-Lacrosniere C., Civeira F., Lanzberg A., et al. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 1994, 107:85-98.
11. Ware C.F. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev 2008, 223:186-201.
12. Gerbod-Giannone M.C., Li Y., Holleboom A., et al. TNFalpha induces ABCA1 through NF-kappaB in macrophages and in phagocytes ingesting apoptotic cells. Proc Natl Acad Sci U S A 2006, 103:3112-3117.
13. Wang Y., Oram J.F. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem 2002, 277:5692-5697.
14. Wang Y., Oram J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway. J Lipid Res 2007, 48:1062-1068.
15. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979, 76:333-337.
16. Mendez A.J., Oram J.F., Bierman E.L. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 1991, 266:10104-10111.
17. Oram J.F., Mendez A.J., Slotte J.P., Johnson T.F. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Arterioscler Thromb 1991, 11:403-414.
18. Wellington C.L., Walker E.K., Suarez A., et al. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab Invest 2002, 82:273-283.
19. Androlewicz M.J., Browning J.L., Ware C.F. Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J Biol Chem 1992, 267:2542-2547.
20. Browning J.L., Androlewicz M.J., Ware C.F. Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma. J Immunol 1991, 147:1230-1237.
21. Browning J.L., Ngam-ek A., Lawton P., et al. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993, 72:847-856.
22. McCarthy D.D., Summers-Deluca L., Vu F., Chiu S., Gao Y., Gommerman J.L. The lymphotoxin pathway: beyond lymph node development. Immunol Res 2006, 35:41-54.
23. Lo J.C., Basak S., James E.S., et al. Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues. Blood. 2006, 107:1048-1055.
24. Schneider K., Potter K.G., Ware C.F. Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 2004, 202:49-66.
25. Aiello R.J., Brees D., Francone O.L. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler Thromb Vasc Biol 2003, 23:972-980.
26. van Eck M., Bos I.S., Kaminski W.E., et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S A 2002, 99:6298-6303.
27. Frikke-Schmidt R., Nordestgaard B.G., Jensen G.B., Steffensen R., Tybjaerg-Hansen A. Genetic variation in ABCA1 predicts ischemic heart disease in the general population. Arterioscler Thromb Vasc Biol 2008, 28:180-186.
28. Singaraja R.R., Fievet C., Castro G., et al. Increased ABCA1 activity protects against atherosclerosis. J Clin Invest 2002, 110:35-42.
29. Schottelius A.J., Moldawer L.L., Dinarello C.A., Asadullah K., Sterry W., Edwards C.K. Biology of tumor necrosis factor-alpha-implications for psoriasis. Exp Dermatol 2004, 13:193-222.
30. Turner N.A., Mughal R.S., Warburton P., O'Regan D.J., Ball S.G., Porter K.E. Mechanism of TNFalpha-induced IL-1alpha. IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. Cardiovasc Res 2007, 76:81-90.
31. Tartaglia L.A., Pennica D., Goeddel D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 1993, 268:18542-18548.
32. Monden Y., Kubota T., Inoue T., et al. Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction. Am J Physiol Heart Circ Physiol 2007, 293:H743-753.
33. Ramani R., Mathier M., Wang P., et al. Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling. Am J Physiol Heart Circ Physiol 2004, 287:H1369-1377.
34. Fujita M., Ikegame S., Harada E., et al. TNF receptor 1 and 2 contribute in different ways to resistance to Legionella pneumophila-induced mortality in mice. Cytokine 2008, 44:298-303.
35. Sedger L.M., Hou S., Osvath S.R., et al. Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha. J Immunol 2002, 169:6193-6201.
36. Togbe D., de Sousa P.L., Fauconnier M., et al. Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS ONE 2008, 3:e2608.
37. Kavurma M.M., Tan N.Y., Bennett M.R. Death receptors and their ligands in atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:1694-1702.
38. Lee N.K., Lee S.Y. Modulation of life and death by the tumor necrosis factor receptor-associated factors (TRAFs). J Biochem Mol Biol 2002, 35:61-66.
39. Derudder E., Dejardin E., Pritchard L.L., Green D.R., Korner M., Baud V. RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. J Biol Chem 2003, 278:23278-23284.
40. Lu R., Arakawa R., Ito-Osumi C., Iwamoto N., Yokoyama S. ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation. Arterioscler Thromb Vasc Biol 2008, 28:1820-1824.
41. Singaraja R.R., Kang M.H., Vaid K., et al. Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function. Circ Res 2009, 105:138-147.
42. Tang C., Oram J.F. The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes. Biochim Biophys Acta 2009, 1791:563-572.
43. Wang N., Chen W., Linsel-Nitschke P., et al. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J Clin Invest 2003, 111:99-107.
44. Chaturvedi M.M., LaPushin R., Aggarwal B.B. Tumor necrosis factor and lymphotoxin. Qualitative and quantitative differences in the mediation of early and late cellular response. J Biol Chem 1994, 269:14575-14583.